Squarepoint’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292K Buy
351,575
+111,634
+47% +$102K ﹤0.01% 3823
2026
Q1
$295K Buy
+239,941
New +$417K ﹤0.01% 3726
2025
Q3
Sell
-21,673
Closed -$84.5K 4484
2025
Q2
$84.5K Buy
+21,673
New +$68.3K ﹤0.01% 4211
2023
Q3
Sell
-13,530
Closed -$149K 3863
2023
Q2
$149K Sell
13,530
-102,928
-88% -$1.06M ﹤0.01% 3287
2023
Q1
$1.2M Buy
116,458
+77,286
+197% +$910K ﹤0.01% 1771
2022
Q4
$431K Buy
+39,172
New +$504K ﹤0.01% 2367
2021
Q4
Sell
-89,500
Closed -$3.83M 3225
2021
Q3
$3.83M Buy
+89,500
New +$3.97M 0.01% 899

Other funds holding DH

Squarepoint's DH Position: Q2 2026 in Review

Squarepoint increased its Definitive Healthcare (DH) stake by 47% in Q2 2026, buying an estimated $102K and bringing the position to 351,575 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #3823.

Squarepoint first reported a position in DH in Q3 2021 and has held it in 7 quarters since. The position peaked at $3.83M in Q3 2021. 100 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • Squarepoint held 351,575 shares of Definitive Healthcare worth $292K as of Q2 2026.
  • Squarepoint bought 111,634 Definitive Healthcare shares in Q2 2026, an estimated $102K.
  • Definitive Healthcare made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3823 holding.
  • Squarepoint first reported a position in Definitive Healthcare in Q3 2021 and has held it in 7 quarters since.
  • Squarepoint's Definitive Healthcare position peaked at $3.83M in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.